Advertisement

The CARE guidelines: consensus-based clinical case report guideline development

Published:September 16, 2013DOI:https://doi.org/10.1016/j.jclinepi.2013.08.003

      Abstract

      Background

      A case report is a narrative that describes, for medical, scientific, or educational purposes, a medical problem experienced by one or more patients. Case reports written without guidance from reporting standards are insufficiently rigorous to guide clinical practice or to inform clinical study design.

      Primary Objective

      Develop, disseminate, and implement systematic reporting guidelines for case reports.

      Methods

      We used a three-phase consensus process consisting of (1) pre-meeting literature review and interviews to generate items for the reporting guidelines, (2) a face-to-face consensus meeting to draft the reporting guidelines, and (3) post-meeting feedback, review, and pilot testing, followed by finalization of the case report guidelines.

      Results

      This consensus process involved 27 participants and resulted in a 13-item checklist—a reporting guideline for case reports. The primary items of the checklist are title, key words, abstract, introduction, patient information, clinical findings, timeline, diagnostic assessment, therapeutic interventions, follow-up and outcomes, discussion, patient perspective, and informed consent.

      Conclusions

      We believe the implementation of the CARE (CAse REport) guidelines by medical journals will improve the completeness and transparency of published case reports and that the systematic aggregation of information from case reports will inform clinical study design, provide early signals of effectiveness and harms, and improve healthcare delivery.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Epidemiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hauben M.
        • Aronson J.K.
        Gold standards in pharmaco-vigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.
        Drug Saf. 2007; 30: 645-655
      1. Vandenbroucke JP. Thalidomide: an unanticipated adverse effect. JLL Bulletin: Commentaries on the history of treatment evaluation. Available at http://www.jameslindlibrary.org/illustrating/articles/thalidomide-an-unanticipated-adverse-effect. Accessed January 10, 2013.

        • Levy M.
        Propranolol for infantile hemangiomas.
        Glob Adv Health Med. 2012; 1: 14-16
        • Jenicek M.
        Clinical case reporting in evidence-based medicine.
        2nd ed. Oxford University Press, New York, NY2001
        • Riley D.
        Case reports in the era of clinical trials.
        Glob Adv Health Med. 2013; 2: 10-11
      2. “Case reports” search results. PubMed, US National Library of Medicine, Bethesda, MD2013 (Available at) (Accessed June 10, 2013)
        • Kaszkin-Bettag M.
        • Hildebrandt W.
        Case report on cancer therapies: the urgent need to improve the reporting quality.
        Glob Adv Health Med. 2012; 1: 8-10
        • Kljakovic M.
        Single cases in general practice and general medical journals.
        Aust Fam Physician. 2002; 31: 669-673
        • Richason T.P.
        • Paulson S.M.
        • Lowenstein S.R.
        • Heard K.J.
        Case reports describing treatments in the emergency medicine literature: missing and misleading information.
        BMC Emerg Med. 2009; 9: 10
        • Schulz K.F.
        • Altman D.G.
        • Moher D.
        CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
        Ann Intern Med. 2010; 152: 726-732
        • von Elm E.
        • Altman D.G.
        • Egger M.
        • Pocock S.J.
        • Gøtzsche P.C.
        • Vandenbroucke J.P.
        STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.
        BMJ. 2007; 335: 806-808
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        • the PRISMA Group
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
        PLoS Med. 2009; 6: e1000097
        • Turner L.
        • Shamseer L.
        • Altman D.G.
        • Schulz K.F.
        • Moher D.
        Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review.
        Syst Rev. 2012; 1: 60
        • Kelly W.N.
        • Arellano F.M.
        • Barnes J.
        • Bergman U.
        • Edwards R.I.
        • Fernandez A.M.
        • et al.
        Guidelines for submitting adverse event reports for publication.
        Drug Saf. 2007; 30: 367-373
        • Moher D.
        • Schulz K.F.
        • Simera I.
        • Altman D.G.
        Guidance for developers of health research reporting guidelines.
        PLoS Med. 2010; 7: e1000217
        • Williams P.L.
        • Webb C.
        The Delphi technique: a methodological discussion.
        J Adv Nurs. 1994; 19: 180-186
        • Thomas B.
        Using nominal group technique to identify researchable problems.
        J Nurs Educ. 1983; 22: 335-337
        • Tully M.P.
        • Cantrill J.A.
        Exploring the domains of appropriateness of drug therapy using the nominal group technique.
        Pharm World Sci. 2002; 24: 128-131
        • Horton J.N.
        Nominal group technique: a method of decision-making by committee.
        Anaesthesia. 1980; 35: 11-14
        • Calvert M.
        • Blazeby J.
        • Altman D.G.
        • Revicki D.A.
        • Moher D.
        • Brundage M.D.
        CONSORT PRO Group. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.
        JAMA. 2013; 309: 814-822
        • Vandenbroucke J.P.
        In defense of case reports and case series.
        Ann Intern Med. 2001; 134: 330-334
      3. Journal of Medical Case Reports. Available at http://www.jmedicalcasereports.com/. Accessed June 17, 2013.

      4. Cases Database. Available at http://www.casesdatabase.com/. Accessed June 17, 2013.

        • Hopewell S.
        • Clarke M.
        • Moher D.
        • Wager E.
        • Middleton P.
        • Altman D.G.
        • et al.
        CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.
        PLoS Med. 2008; 5: e20
        • Hopewell S.
        • Ravaud P.
        • Baron G.
        • Boutron I.
        Effect of editors implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis.
        BMJ. 2012; 344: e4178
        • Hirst A.
        • Altman D.G.
        Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals.
        PLoS One. 2012; 7: e35621
        • Hill A.B.
        The environment and disease: association or causation?.
        Proc R Soc Med. 1965; 58: 295
        • Kiene H.
        • Hamre H.
        • Kienle G.
        In support of clinical case reports: a system of causality assessment.
        Glob Adv Health Med. 2013; 2: 76-87